Airway Mucus Hyperconcentration in Non–Cystic Fibrosis Bronchiectasis
- 15 March 2020
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 201 (6), 661-670
- https://doi.org/10.1164/rccm.201906-1219oc
Abstract
Rationale: Non–cystic fibrosis bronchiectasis is characterized by airway mucus accumulation and sputum production, but the role of mucus concentration in the pathogenesis of these abnormalities has not been characterized. Objectives: This study was designed to: 1) measure mucus concentration and biophysical properties of bronchiectasis mucus; 2) identify the secreted mucins contained in bronchiectasis mucus; 3) relate mucus properties to airway epithelial mucin RNA/protein expression; and 4) explore relationships between mucus hyperconcentration and disease severity. Methods: Sputum samples were collected from subjects with bronchiectasis, with and without chronic erythromycin administration, and healthy control subjects. Sputum percent solid concentrations, total and individual mucin concentrations, osmotic pressures, rheological properties, and inflammatory mediators were measured. Intracellular mucins were measured in endobronchial biopsies by immunohistochemistry and gene expression. MUC5B (mucin 5B) polymorphisms were identified by quantitative PCR. In a replication bronchiectasis cohort, spontaneously expectorated and hypertonic saline-induced sputa were collected, and mucus/mucin concentrations were measured. Measurements and Main Results: Bronchiectasis sputum exhibited increased percent solids, total and individual (MUC5B and MUC5AC) mucin concentrations, osmotic pressure, and elastic and viscous moduli compared with healthy sputum. Within subjects with bronchiectasis, sputum percent solids correlated inversely with FEV1 and positively with bronchiectasis extent, as measured by high-resolution computed tomography, and inflammatory mediators. No difference was detected in MUC5B rs35705950 SNP allele frequency between bronchiectasis and healthy individuals. Hypertonic saline inhalation acutely reduced non–cystic fibrosis bronchiectasis mucus concentration by 5%. Conclusions: Hyperconcentrated airway mucus is characteristic of subjects with bronchiectasis, likely contributes to disease pathophysiology, and may be a target for pharmacotherapy.Keywords
This publication has 39 references indexed in Scilit:
- MUC5B Promoter Polymorphism and Interstitial Lung AbnormalitiesThe New England Journal of Medicine, 2013
- A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway EpitheliaScience, 2012
- Receptor‐promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotidesJournal Of Physiology-London, 2010
- MUC5B Is the Major Mucin in the Gel Phase of Sputum in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Hypoxia inducible factor‐1 (HIF‐l)‐mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epitheliumThe FASEB Journal, 2008
- Coordinated release of nucleotides and mucin from human airway epithelial Calu‐3 cellsJournal Of Physiology-London, 2007
- Neutrophil elastase activates near-silent epithelial Na+channels and increases airway epithelial Na+transportAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lungRespiratory Medicine, 2002
- Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5BBiochemical Journal, 2002
- A Study of the Pathology and Pathogenesis of BronchiectasisThorax, 1952